
Metozaar 12.5mg Tablet XL
Marketer
Corona Remedies Pvt Ltd
Salt Composition
Metoprolol Succinate (12.5mg)
Overview Metozaar 12.5mg Tablet XL
Extended-release Metozaar 12.5mg tablets are beta-blockers used to manage hypertension, angina pectoris, and cardiac arrhythmias. They also help prevent migraines and reduce the risk of future strokes and myocardial infarctions. Metozaar 12.5mg XL may be prescribed as monotherapy or in combination with other drugs, with dosage tailored to individual needs and condition severity. Administer consistently at the same time daily, regardless of food intake, for optimal efficacy. Full therapeutic benefit may take weeks to manifest; continuous use, even during symptom remission, is crucial. Discontinuation may exacerbate underlying conditions. Common, usually transient, side effects include fatigue, cephalalgia, depressive symptoms, diarrhea, skin rashes, bradycardia, dizziness, and nausea. Less frequently, it can cause dyspnea or hypotension. Gradual dose escalation minimizes adverse effects. Report persistent or bothersome side effects to your physician. Prior to initiating therapy, disclose any liver impairment to your doctor. Metozaar 12.5mg XL is contraindicated in individuals with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating women require medical consultation before use. Always consult your physician to determine suitability and ensure regular blood pressure monitoring to assess treatment effectiveness. Alcohol consumption should be minimized due to the potential for increased side effect incidence.
Uses of Metozaar 12.5mg Tablet XL
Managing angina pectoris (chest pain from heart issues)|Correcting cardiac arrhythmias|Preventing myocardial infarction|Treating arterial hypertension (high blood pressure)|Migraine prophylaxis
Major Benefits of Metozaar 12.5mg Tablet XL:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Metozaar 12.5mg Tablet XL whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistent timing is recommended. To maximize effectiveness, avoid consuming Metozaar 12.5mg Tablet XL with meals high in fat, including foods like olive oil, nuts and seeds (especially Brazil nuts), dark chocolate, butter, and red meat.
Common Side effects of Metozaar 12.5mg Tablet XL:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metozaar 12.5mg Tablet XL:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Metozaar 12.5mg Extended-Release Tablets may be consumed with or without food, though consistent timing is recommended. Limit consumption of Metozaar 12.5mg Extended-Release Tablets with high-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and meat.
How Metozaar 12.5mg Tablet XL works:
Extended-release Metozaar 12.5mg tablets are a cardioselective beta-adrenergic blocking agent. They reduce heart rate and improve the heart's pumping efficiency, promoting systemic blood circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metozaar 12.5mg Tablet XL and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metozaar 12.5mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metozaar 12.5mg tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Metozaar 12.5mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Metozaar 12.5mg tablets are considered safe for individuals with renal impairment. No dosage modification is advised for Metozaar 12.5mg extended-release tablets in this population.
LiverCAUTION
Extended-release Metozaar 12.5mg tablets require careful administration for individuals with hepatic impairment. Dosage modification of Metozaar 12.5mg extended-release tablets may be necessary. Physician consultation is recommended.
What if you forget to take Metozaar 12.5mg Tablet XL :
Should you forget a Metozaar 12.5mg Tablet XL dose, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Metozaar 12.5mg Tablet XL
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |
